Characteristics of Patients With Sulphonurea-Induced Hypoglycemia

Journal of the American Medical Directors Association

Volumn 13, Issue 3, 2012, Pages 234-238

  Schejter, Yael Dinur ^a   Turvall, Elliot ^a   Ackerman, Zvi ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Elderly; Hypoglycemia; Malnutrition; Renal failure; Sulphonylurea; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CEPHALOSPORIN DERIVATIVE; CREATININE; CYANOCOBALAMIN; FIBRIC ACID DERIVATIVE; FOLIC ACID; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE; GLIMEPIRIDE PLUS METFORMIN; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; METFORMIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; REPAGLINIDE; STEROID; SULFONYLUREA; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; WARFARIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL PERITONITIS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL EXAMINATION; COMORBIDITY; CONGESTIVE HEART FAILURE; COUGHING; CREATININE BLOOD LEVEL; CYANOCOBALAMIN DEFICIENCY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIARRHEA; DISEASE PREDISPOSITION; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG USE; DYSPNEA; DYSURIA; FATTY LIVER; FEMALE; FEVER; FRAIL ELDERLY; GLYCEMIC CONTROL; HEART MUSCLE ISCHEMIA; HEMIPARESIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTHYROIDISM; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LABORATORY TEST; LENGTH OF STAY; LIVER DISEASE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL RECORD REVIEW; MICROALBUMINURIA; MICTURITION DISORDER; MORTALITY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PERITONITIS; RISK ASSESSMENT; RISK FACTOR; SKIN INFECTION; THORAX RADIOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; URINARY TRACT INFECTION; URINE CULTURE; VOMITING;

EID: 84857192367     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.07.014     Document Type: Article

References (39)

1. Schernthaner G. Diabetes and cardiovascular disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Wien Med Wochenschr 2010, 160:8-19.
2. Montori V.M., Fernández-Balsells M. Glycemic control in type 2 diabetes: Time for an evidence-based about-face?. Ann Intern Med 2009, 150:803-808.
3. Nathan D.M., Buse J.B., Davidson M.B., et al. American Diabetes Association. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203.
4. Burge M.R., Sood V., Sobhy T.A., et al. Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: A review. Diabetes Obes Metab 1999, 1:199-206.
5. Ben-Ami H., Nagachandran P., Mendelson A., Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 1999, 159:281-284.
6. Cryer P.E., Axelrod L., Grossman A.B., et al. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009, 94:709-728.
7. Holstein A., Plaschke A., Egberts E.H. Clinical characterisation of severe hypoglycaemia-A prospective population-based study. Exp Clin Endocrinol Diabetes 2003, 111:364-369.
8. Holstein A., Plaschke A., Ptak M., et al. Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents. Br J Clin Pharmacol 2005, 60:103-106.
9. Thamer M., Ray N.F., Taylor T. Association between antihypertensive drug use and hypoglycemia: A case-control study of diabetic users of insulin or sulfonylureas. Clin Ther 1999, 21:1387-1400.
10. Rave K., Flesch S., Kühn-Velten W.N., et al. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: Results of a glucose-clamp study. Diabetes Metab Res Rev 2005, 21:459-464.
11. Micossi P., Pontiroli A.E., Baron S.H., et al. Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes 1978, 27:1196-1204.
12. Barnett A.H., Leslie D., Watkins P.J. Can insulin-treated diabetics be given beta-adrenergic blocking drugs?. Br Med J 1980, 280:976-978.
13. Lawrence A.M., Ajlouni K., Hagen T.C. Chronic propranolol administration impairs glucagon release during insulin-induced hypoglycemia in normal man. J Clin Endocrinol Metab 1984, 59:622-624.
14. Corsonello A., Pedone C., Corica F., et al. Antihypertensive drug therapy and hypoglycemia in elderly diabetic patients treated with insulin and/or sulfonylureas. Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA). Eur J Epidemiol 1999, 15:893-901.
15. Murad M.H., Coto-Yglesias F., Wang A.T., et al. Clinical review: Drug-induced hypoglycemia: A systematic review. J Clin Endocrinol Metab 2009, 94:741-745.
16. Gangji A.S., Cukierman T., Gerstein H.C., et al. A systematic review and meta-analysis of hypoglycemia and cardiovascular events: A comparison of glyburide with other secretagogues and with insulin. Diabetes Care 2007, 30:389-394.
17. Bolen S., Feldman L., Vassy J., et al. Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007, 147:386-399.
18. Arinzon Z., Fidelman Z., Berner Y.N., Adunsky A. Infection-related hypoglycemia in institutionalized demented patients: A comparative study of diabetic and nondiabetic patients. Arch Gerontol Geriatr 2007, 45:191-200.
19. Hornick T., Aron D.C. Managing diabetes in the elderly: Go easy; individualize. Cleve Clin J Med 2008, 75:70-78.
20. Kooman J.P., Leunissen K.M. Malnutrition in patients with end-stage renal disease: Diagnosis, pathophysiology and treatment. Neth J Med 1997, 50:120-132.
21. Haviv Y.S., Sharkia M., Safadi R. Hypoglycemia in patients with renal failure. Ren Fail 2000, 22:219-223.
22. Holstein A., Plaschke A., Hammer C., Egberts E.H. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. Eur J Clin Pharmacol 2003, 59:91-97.
23. Moen M.F., Zhan M., Hsu V.D., et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:1121-1127.
24. Snyder R.W., Berns J.S. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial 2004, 17:365-370.
25. van der Crabben S.N., Blümer R.M., Stegenga M.E., et al. Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans. J Clin Endocrinol Metab 2009, 94:463-468.
26. Balasubramanyam A. Intensive glycemic control in the intensive care unit: Promises and pitfalls. J Clin Endocrinol Metab 2009, 94:416-417.
27. Metzger S., Nusair S., Planer D., et al. Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta- secreting tumor. Endocrinology 2004, 145:5150-5156.
28. Tirosh O., Artan A., Aharoni-Simon M., et al. Impaired liver glucose production in a murine model of steatosis and endotoxemia: Protection by inducible nitric oxide synthase. Antioxid Redox Signal 2010, 13:13-26.
29. Targher G., Chonchol M., Bertolini L., et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 2008, 19:1564-1570.
30. Zelber-Sagi S., Nitzan-Kaluski D., Halpern Z., Oren R. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels. J Hepatol 2007, 46:700-707.
31. Trombini P., Piperno A. Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons. J Hepatol 2007, 46:549-552.
32. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
33. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
34. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139. VADT Investigators.
35. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
36. Greco D., Angileri G. Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older. Diabetes Nutr Metab 2004, 17:23-26.
37. Feldman S.M., Rosen R., DeStasio J. Status of diabetes management in the nursing home setting in 2008: A retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. J Am Med Dir Assoc 2009, 10:354-360.
38. Turchin A., Matheny M.E., Shubina M., et al. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009, 32:1153-1157.
39. Haneda M., Morikawa A. Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?. Nephrol Dial Transplant 2009, 24:338-341.